Denali Therapeutics Inc. DNLI Increase in right-of-use asset due to lessor assets
Increase in right-of-use asset due to lessor assets at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept dnli:IncreaseInRightOfUseAssetDueToLessorAssets.
The official record: Denali Therapeutics Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s increase in right-of-use asset due to lessor assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s increase in right-of-use asset due to lessor assets?
- Denali Therapeutics Inc. (DNLI) reported increase in right-of-use asset due to lessor assets of $0 in Q4 2025.
- How has Denali Therapeutics Inc.'s increase in right-of-use asset due to lessor assets changed year-over-year?
- Denali Therapeutics Inc.'s increase in right-of-use asset due to lessor assets decreased by 100.0% year-over-year, from $1.76M to $0.
- What does increase in right-of-use asset due to lessor assets mean?
- This represents the non-cash addition to the company's right-of-use assets resulting from new lease agreements or modifications to existing leases. It provides visibility into the company's expansion of its leased asset base without immediate cash outlay. This metric is essential for understanding the company's off-balance-sheet financing commitments and future lease obligations.